Balancing innovation, regulation and a symbiotic relationship with the medical industry it oversees is a tricky task for the agency. The Associated Press takes a look at the FDA's push for quick approvals and how that may have lead to problems with current devices on the market.

from Kaiser Health News https://ift.tt/2DP0uVh

Related Posts:

0 comments:

Post a Comment

Popular Posts